Anxiety Disorders is an indication for drug development with over 260 pipeline drugs currently active. According to GlobalData, preregistered drugs for Anxiety Disorders have a 80% likelihood of approval (LoA) indication benchmark. GlobalData’s report assesses how phase transition success rate (PTSR) and likelihood of approval (LoA) scores for pipeline drugs in Anxiety Disorders compared to historical benchmarks. Buy the report here.
Smarter leaders trust GlobalData
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.
Anxiety Disorders overview
Anxiety disorders are a group of mental health conditions characterized by excessive and persistent worry, fear, or anxiety that can significantly impact an individual’s daily life. Anxiety disorders can vary in their presentation and severity, and they often involve a combination of genetic, biological, environmental, and psychological factors. Symptoms vary depending on the type of anxiety disorder.
For a complete picture of PTSR and LoA scores for drugs in Anxiety Disorders, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Likelihood of Approval analytics tool dynamically assesses and predicts how likely a drug will move to the next stage in clinical development (PTSR), as well as how likely the drug will be approved (LoA). This is based on a combination of machine learning and a proprietary algorithm to process data points from various databases found on GlobalData’s Pharmaceutical Intelligence Center.
